Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Establishment of patient- or person-specific cardiac myocyte cell lines from human induced pluripotent stem cells (iPSCs)

Establishment of patient- or person-specific cardiac myocyte cell lines from human induced pluripotent stem cells (iPSCs)

US Patent 9155765 · Granted Oct 13, 2015

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Triheptanoin for the treatment of glucose transport 1 deficiency2018
Urinary triaosylceramide (Gb3) as a marker of cardiac disease2017
Triheptanoin for the treatment of glucose transport 1 deficiency2016
Urinary triaosylceramide (GB3) as a marker of cardiac disease2015
Use of tetrahydrobiopterin as a marker and a therapeutic agent for fabry disease2013